Closing the Post-TAVR Care Gap

Transcatheter aortic valve replacement has transformed the treatment of aortic stenosis. Procedural success rates are high, and early mortality has declined significantly. But a successful valve replacement doesn't guarantee a successful recovery — and the data on what happens after discharge tells a more complicated story than the procedure itself.

The valve gets fixed. The risk doesn't disappear.

More than one in five TAVR patients experience a heart failure hospitalization within a year. Roughly two-thirds of deaths in this population are non-cardiac, driven by infection and systemic decline that standard post-discharge care isn't built to catch. The patient becomes clinically invisible the moment they walk out of the hospital — that's the actual problem.

SYNC-PREVENT™ closes that gap by transitioning every TAVR patient — not just the ones who already look high-risk — into continuous monitoring at discharge. Hemodynamic monitoring establishes a baseline filling pressure and flags residual congestion. An ECG patch covers arrhythmia surveillance for the first 30 days, followed by intermittent monitoring through day 90. Weight, blood pressure, heart rate, and oxygen trends surface heart failure symptoms roughly one to two weeks earlier than they'd otherwise appear.

Two signals for infection, not one

Infection surveillance runs continuously for the first 60 days — the window where sepsis and systemic decline do the most damage and get watched the least — through both continuous temperature monitoring and physician-ordered biomarker testing. The biomarkers (hs-CRP, serum albumin, lymphocyte count) compute automatically into a composite infection-risk score, using labs many patients are already having drawn. No additional testing is required to generate it.

“This is the part that matters most: two independent signals for infection — continuous device-based temperature monitoring and provider-ordered biomarker testing — instead of relying on either one alone.”

The interoperability layer also pulls the discharging physician's summary directly into the monitoring record, closing the medication-reconciliation gap that drives a meaningful share of post-procedure readmissions. TAVR solves the valve. What happens in the following ninety days is what SYNC-PREVENT™ is built to watch.